|
|
| |
| |
 |
 |
| ImQuest BioSciences, Inc. is one of the world's leading providers of services ranging from anti - infective drug and vaccine discovery and complete preclinical therapeutic development to basic initiatives in microbiology research. Our technical and professional expertise includes microbiology (virology, bacteriology, mycology), molecular biology, cell biology, immunology, flow cytometry and tissue culture. Our multidisciplinary approach to infectious disease and cancer research allows for the rapid development of technologically current and novel programs that are required to solve the research problems of your drug development program. |
 |
Mission Statement :
To develop highly interactive client relationships that will allow us to provide expert and efficient preclinical discovery, development and consulting services to facilitate the timely submission of IND’s, and to define and implement viable solutions to our client’s therapeutic development programs. |
| |
|
| |
| Anti-Infective Services: |
 |
| |
| We have decades of relevant experience in the development of anti - infective therapeutics (drugs, vaccines, immune modulators and other biologics), including HIV, hepatitis B and C, influenza and respiratory viruses, herpes viruses, enteric viruses, veterinary viruses, wild type and resistant bacteria, sexually transmitted infections, and fungi, according to the Points to Consider documents of the Food and Drug Administration. |
|
 |
| |
| Anti-Cancer Services: |
 |
| |
| With expertise in cancer research that is deeply founded on core tissue culture, cell biology and molecular biology capabilities. ImQuest's cancer and in-vitro toxicology laboratory supports the rapid evaluation of the anti - proliferative, cell - based, molecular and and biochemical effects of cancer therapeutics. |
|
|
| |
| Immunoassay Services: |
 |
| |
| The current trend involving the development of biologics, including proteins, peptides and therapeutic antibodies, has resulted in new drug development challenges that require intimate understanding of immunology, cell-based and ELISA development, ELISPOT and Intracellular Cytokine Staining development, and GLP-compliant product development. |
|
|
|
|
| |
| |
| Copyright © 2006, ImQuest BioSciences. | | | |
| | | | | |
| | | | |
| |
|
|
